Human Genome Epidemiology Literature Finder
Records 1 - 20 (of 20 Records) |
Query Trace: Astrocytoma and IDH2[original query] |
---|
Analysis of IDH1 and IDH2 mutations in Japanese glioma patients. Cancer science 2009 Oct 100 (10): 1996-8. Sonoda Yukihiko, Kumabe Toshihiro, Nakamura Taigen, Saito Ryuta, Kanamori Masayuki, Yamashita Yoji, Suzuki Hiroyoshi, Tominaga Tei |
Type and frequency of IDH1 and IDH2 mutations are related to astrocytic and oligodendroglial differentiation and age: a study of 1,010 diffuse gliomas. Acta neuropathologica 2009 Oct 118 (4): 469-74. Hartmann Christian, Meyer Jochen, Balss Jörg, Capper David, Mueller Wolf, Christians Arne, Felsberg Jörg, Wolter Marietta, Mawrin Christian, Wick Wolfgang, Weller Michael, Herold-Mende Christel, Unterberg Andreas, Jeuken Judith W M, Wesseling Peter, Reifenberger Guido, von Deimling Andre |
IDH1 mutations in low-grade astrocytomas predict survival but not response to temozolomide. Neurology 2009 Nov 73 (21): 1792-5. Dubbink H J, Taal W, van Marion R, Kros J M, van Heuvel I, Bromberg J E, Zonnenberg B A, Zonnenberg C B L, Postma T J, Gijtenbeek J M M, Boogerd W, Groenendijk F H, Smitt P A E Sillevis, Dinjens W N M, van den Bent M |
First-line temozolomide chemotherapy in progressive low-grade astrocytomas after radiotherapy: molecular characteristics in relation to response. Neuro-oncology 2011 Feb 13 (2): 235-41. Taal Walter, Dubbink Hendrikus J, Zonnenberg Chris B L, Zonnenberg Bernard A, Postma Tjeerd J, Gijtenbeek Johanna M M, Boogerd Willem, Groenendijk Floris H, Kros Johan M, Kouwenhoven Mathilde C M, van Marion Ronald, van Heuvel Irene, van der Holt Bronno, Bromberg Jacoline E C, Sillevis Smitt Peter A E, Dinjens Winand N M, van den Bent Martin J, |
Molecular classification of low-grade diffuse gliomas. The American journal of pathology 2010 Dec 177 (6): 2708-14. Kim Young-Ho, Nobusawa Sumihito, Mittelbronn Michel, Paulus Werner, Brokinkel Benjamin, Keyvani Kathy, Sure Ulrich, Wrede Karsten, Nakazato Yoichi, Tanaka Yuko, Vital Anne, Mariani Luigi, Stawski Robert, Watanabe Takuya, De Girolami Umberto, Kleihues Paul, Ohgaki Hiro |
IDH mutations occur frequently in Chinese glioma patients and predict longer survival but not response to concomitant chemoradiotherapy in anaplastic gliomas. Oncology reports 2011 Dec 26 (6): 1479-85. Qi Song-Tao, Yu Lei, Lu Yun-Tao, Ou Yang-Hui, Li Zhi-Yong, Wu Lan-Xiao, Yao F |
IDH1/2 mutations in WHO grade II astrocytomas associated with localization and seizure as the initial symptom. Seizure 2012 Apr 21 (3): 194-7. Stockhammer Florian, Misch Martin, Helms Hans-Joachim, Lengler Ulrike, Prall Friedrich, von Deimling Andreas, Hartmann Christi |
Correlation of IDH1/2 mutation with clinicopathologic factors and prognosis in anaplastic gliomas: a report of 203 patients from China. Journal of cancer research and clinical oncology 2014 Jan 140 (1): 45-51. Zhang Chuan-Bao, Bao Zhao-Shi, Wang Hong-Jun, Yan Wei, Liu Yan-Wei, Li Ming-Yang, Zhang Wei, Chen Ling, Jiang T |
The impact of concurrent temozolomide with adjuvant radiation and IDH mutation status among patients with anaplastic astrocytoma. Journal of neuro-oncology 2014 Oct 120 (1): 85-93. Kizilbash Sani H, Giannini Caterina, Voss Jesse S, Decker Paul A, Jenkins Robert B, Hardie John, Laack Nadia N, Parney Ian F, Uhm Joon H, Buckner Jan |
Molecular investigation of isocitrate dehydrogenase gene (IDH) mutations in gliomas: first report of IDH2 mutations in Indian patients. Asian Pacific journal of cancer prevention : APJCP 2013 14 (12): 7261-4. Das Bibhu Ranjan, Tangri Rajiv, Ahmad Firoz, Roy Arnab, Patole Kamlak |
Molecular classification of anaplastic oligodendroglioma using next-generation sequencing: a report of the prospective randomized EORTC Brain Tumor Group 26951 phase III trial. Neuro-oncology 2015 Sep . Dubbink Hendrikus J, Atmodimedjo Peggy N, Kros Johan M, French Pim J, Sanson Marc, Idbaih Ahmed, Wesseling Pieter, Enting Roelien, Spliet Wim, Tijssen Cees, Dinjens Winand N M, Gorlia Thierry, van den Bent Martin |
Genetic and epigenetic characterization of low-grade gliomas reveals frequent methylation of the MLH3 gene. Genes, chromosomes & cancer 2015 Nov 54 (11): 655-67. Lhotska Halka, Zemanova Zuzana, Cechova Hana, Ransdorfova Sarka, Lizcova Libuse, Kramar Filip, Krejcik Zdenek, Svobodova Karla, Bystricka Dagmar, Hrabal Petr, Dohnalova Alena, Michalova Ky |
The frequency and prognostic effect of TERT promoter mutation in diffuse gliomas. Acta neuropathologica communications 2017 Aug 5 (1): 62. Lee Yujin, Koh Jaemoon, Kim Seong-Ik, Won Jae Kyung, Park Chul-Kee, Choi Seung Hong, Park Sung-H |
Granular cell astrocytoma: an aggressive IDH-wildtype diffuse glioma with molecular genetic features of primary glioblastoma. Brain pathology (Zurich, Switzerland) 2018 Sep . Vizcaino M Adelita, Palsgrove Doreen N, Yuan Ming, Giannini Caterina, Cabrera-Aldana Eibar Ernesto, Pallavajjala Aparna, Burger Peter C, Rodriguez Fausto |
Molecular Diagnosis of Diffuse Gliomas through Sequencing of Cell-Free Circulating Tumor DNA from Cerebrospinal Fluid. Clinical cancer research : an official journal of the American Association for Cancer Research 2018 4 24 (12): 2812-2819. Martínez-Ricarte Francisco, Mayor Regina, Martínez-Sáez Elena, Rubio-Pérez Carlota, Pineda Estela, Cordero Esteban, Cicuéndez Marta, Poca Maria A, López-Bigas Nuria, Ramon Y Cajal Santiago, Vieito María, Carles Joan, Tabernero Josep, Vivancos Ana, Gallego Soledad, Graus Francesc, Sahuquillo Juan, Seoane Jo |
Association of the FGFR1 mutation with spontaneous hemorrhage in low-grade gliomas in pediatric and young adult patients. Journal of neurosurgery 2020 2 134 (3): 733-741. Ishi Yukitomo, Yamaguchi Shigeru, Hatanaka Kanako C, Okamoto Michinari, Motegi Hiroaki, Kobayashi Hiroyuki, Terasaka Shunsuke, Houkin Kiyohi |
EGFRvIII expression and isocitrate dehydrogenase mutations in patients with glioma. Oncology letters 2020 Dec 20 (6): 384. Taher Mohiuddin M, Dairi Ghida, Butt Ejaz Muhammad, Al-Quthami Khalid, Al-Khalidi Hisham, Jastania Raid A, Nageeti Tahani H, Bogari Neda M, Athar Mohammad, Al-Allaf Faisal A, Valerie Kristoff |
Evaluation of the melting temperature of TaqMan probes as a genotyping method for IDH1, IDH2, and H3F3A in pediatric astrocytomas. Boletin medico del Hospital Infantil de Mexico 2020 11 77 (6): 303-311. Torres-Caballero Aranxa, Serrato Amarantha, López-Santaella Tayde, Ortiz Rosario, León Fernando Chico-Ponce de, González-Carranza Vicente, Torres-García Samuel, Arenas-Huertero Francisco, Hernández-Hernández Abrah |
Multicenter Phase II Trial of the PARP Inhibitor Olaparib in Recurrent IDH1- and IDH2-mutant Glioma. Cancer research communications 2023 3 3 (2): 192-201. Fanucci Kristina, Pilat Mary Jo, Shyr Derek, Shyr Yu, Boerner Scott, Li Jing, Durecki Diane, Drappatz Jan, Puduvalli Vinay, Lieberman Frank Scott, Gonzalez Javier, Giglio Pierre, Ivy S Percy, Bindra Ranjit S, Omuro Antonio, LoRusso Patric |
The Cancer Driver Genes IDH1 and IDH2 and CD204 in WHO-Grade 4 Astrocytoma: Crosstalk Between Cancer Metabolism and Tumour Associated Macrophage Recruitment in Tumour Microenvironment. Biologics : targets & therapy 2023 2 17 15-22. Kurdi Maher, Mulla Nasser, Katib Yousef, Alsinani Taghreed, Hakamy Sahar, Mj Addas Bassam, Malibary Husam, Halawa Taher F, S Farhan Marwa, Faizo Eyad, Baeesa Sal |
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 22, 2024
- Content source: